Prof. Dr. Dr. Stefanie Corradini

Lehrstuhl für Strahlentherapie Department of Radiation Oncology

An ESTRO-ACROP guideline on quality assurance and medical physics commissioning of online MRI guided radiotherapy systems based on a consensus expert opinion (2023) Tanadini-Lang S, Budgell G, Bohoudi O, Corradini S, Cusumano D, Güngör G, Kerkmeijer LG, et al. Journal article Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board (2023) Dorman K, Zhang D, Heinrich K, Reeh L, Weiss L, Haas M, Beyer G, et al. Journal article Patient-specific transfer learning for auto-segmentation in adaptive 0.35 T MRgRT of prostate cancer: a bi-centric evaluation (2023) Kawula M, Hadi I, Nierer L, Vagni M, Cusumano D, Boldrini L, Placidi L, et al. Journal article Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis (2023) Bodensohn R, Werner S, Reis J, Pazos Escudero M, Kaempfel AL, Hadi I, Forbrig R, et al. Journal article “New” Kid on the Block: Interstitial Brachytherapy (2023) Corradini S, Seidensticker M Journal article Survey on brachytherapy training among radiation oncology residents in the German-speaking regions of Europe (2023) Knoth J, Konrad S, Lössl K, Motisi L, Mäurer M, Linde P, Lindel K, et al. Journal article Hyperthermia in the treatment of high-risk soft tissue sarcomas: a systematic review (2023) Veltsista PD, Oberacker E, Ademaj A, Corradini S, Eckert F, Flörcken A, Kaul D, et al. Journal article, Review article Cancer of unknown primary (CUP) through the lens of precision oncology: a single institution perspective (2023) Weiss L, Heinrich K, Zhang D, Dorman K, Rühlmann K, Hasselmann K, Klauschen F, et al. Journal article Prognostic markers for the clinical course in the blood of patients with SARS-CoV-2 infection (2022) Fischer JC, Balz V, Jazmati D, Bölke E, Freise NF, Keitel V, Feldt T, et al. Journal article MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial (2022) Hoegen P, Zhang KS, Tonndorf-Martini E, Weykamp F, Regnery S, Naumann P, Lang K, et al. Journal article